Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (322), 10.1186/s13046-021-02125-z)

Oxana Schmidt; Nadja Nehls; Carolin Prexler; Kristina von Heyking; Tanja Groll; Katharina Pardon; Heathcliff D. Garcia; Tim Hensel; Dennis Gürgen; Anton G. Henssen; Angelika Eggert; Katja Steiger; Stefan Burdach; Günther H.S. Richter

doi:10.1186/s13046-021-02174-4

Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (322), 10.1186/s13046-021-02125-z)

Oxana Schmidt, Nadja Nehls, Carolin Prexler, Kristina von Heyking, Tanja Groll, Katharina Pardon, Heathcliff D. Garcia, Tim Hensel, Dennis Gürgen, Anton G. Henssen, Angelika Eggert, Katja Steiger, Stefan Burdach, Günther H.S. Richter

Publikation: Beitrag in Fachzeitschrift › Kommentar/Debatte

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Originalsprache	Englisch
Aufsatznummer	7
Fachzeitschrift	Journal of Experimental and Clinical Cancer Research
Jahrgang	41
Ausgabenummer	1
DOIs	https://doi.org/10.1186/s13046-021-02174-4
Publikationsstatus	Veröffentlicht - Dez. 2022
Extern publiziert	Ja

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.1186/s13046-021-02174-4

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Fingerprint

Untersuchen Sie die Forschungsthemen von „Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (322), 10.1186/s13046-021-02125-z)“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren

Schmidt, O., Nehls, N., Prexler, C., von Heyking, K., Groll, T., Pardon, K., Garcia, H. D., Hensel, T., Gürgen, D., Henssen, A. G., Eggert, A., Steiger, K., Burdach, S., & Richter, G. H. S. (2022). Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (322), 10.1186/s13046-021-02125-z). Journal of Experimental and Clinical Cancer Research, 41(1), Artikel 7. https://doi.org/10.1186/s13046-021-02174-4

@article{9a20833e832b426c9d91381bacea992a,

title = "Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (322), 10.1186/s13046-021-02125-z)",

abstract = "An amendment to this paper has been published and can be accessed via the original article.",

author = "Oxana Schmidt and Nadja Nehls and Carolin Prexler and {von Heyking}, Kristina and Tanja Groll and Katharina Pardon and Garcia, {Heathcliff D.} and Tim Hensel and Dennis G{\"u}rgen and Henssen, {Anton G.} and Angelika Eggert and Katja Steiger and Stefan Burdach and Richter, {G{\"u}nther H.S.}",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2022",

month = dec,

doi = "10.1186/s13046-021-02174-4",

language = "English",

volume = "41",

journal = "Journal of Experimental and Clinical Cancer Research",

issn = "0392-9078",

publisher = "BioMed Central Ltd.",

number = "1",

}

Schmidt, O, Nehls, N, Prexler, C, von Heyking, K, Groll, T, Pardon, K, Garcia, HD, Hensel, T, Gürgen, D, Henssen, AG, Eggert, A, Steiger, K, Burdach, S & Richter, GHS 2022, 'Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (322), 10.1186/s13046-021-02125-z)', Journal of Experimental and Clinical Cancer Research, Jg. 41, Nr. 1, 7. https://doi.org/10.1186/s13046-021-02174-4

Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (322), 10.1186/s13046-021-02125-z). / Schmidt, Oxana; Nehls, Nadja; Prexler, Carolin et al.
in: Journal of Experimental and Clinical Cancer Research, Jahrgang 41, Nr. 1, 7, 12.2022.

Publikation: Beitrag in Fachzeitschrift › Kommentar/Debatte

TY - JOUR

T1 - Correction to

T2 - Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (322), 10.1186/s13046-021-02125-z)

AU - Schmidt, Oxana

AU - Nehls, Nadja

AU - Prexler, Carolin

AU - von Heyking, Kristina

AU - Groll, Tanja

AU - Pardon, Katharina

AU - Garcia, Heathcliff D.

AU - Hensel, Tim

AU - Gürgen, Dennis

AU - Henssen, Anton G.

AU - Eggert, Angelika

AU - Steiger, Katja

AU - Burdach, Stefan

AU - Richter, Günther H.S.

PY - 2022/12

Y1 - 2022/12

N2 - An amendment to this paper has been published and can be accessed via the original article.

AB - An amendment to this paper has been published and can be accessed via the original article.

UR - http://www.scopus.com/inward/record.url?scp=85122188417&partnerID=8YFLogxK

U2 - 10.1186/s13046-021-02174-4

DO - 10.1186/s13046-021-02174-4

M3 - Comment/debate

C2 - 34980229

AN - SCOPUS:85122188417

SN - 0392-9078

VL - 41

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

IS - 1

M1 - 7

ER -

Schmidt O, Nehls N, Prexler C, von Heyking K, Groll T, Pardon K et al. Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (322), 10.1186/s13046-021-02125-z). Journal of Experimental and Clinical Cancer Research. 2022 Dez;41(1):7. doi: 10.1186/s13046-021-02174-4